Skip to main content

Table 1 Clinical and Biological Expressions of Chylomicron Retention Disease in Studies with Genotyping

From: Guidelines for the diagnosis and management of chylomicron retention disease based on a review of the literature and the experience of two centers

Clinical signs

Age at onset of symptoms

Transient or permanent symptoms

Prevalence in childhood

Power of discrimination

Anthropometry

    

Failure to thrive

Infancy (1 to 6 m)

transient if low LCFA diet

80%

+

Gastrointestinal symptoms and signs

    

Diarrhea

Infancy (1 to 6 m)

transient if low LCFA diet

100%

+

Vomiting

Infancy (1 to 6 m)

transient if low LCFA diet

60%

+

Abdominal distension

Infancy (1 to 6 m)

transient if low LCFA diet

65%

+

Hepatomegaly, Steatosis

Infancy or late childhood

transit or permanent

15%

 

Neurology

    

Retinopathy

Adult

permanent

100%

+++

Visual abnormalities

Late childhood or adult (6 to 10 y)

transient if early treatment

30%

+

Hypo or Areflexia

Late childhood or adult (4 to 10 y)

permanent

5%

+

Myopathy

Adult

permanent

0%

+

EMG abnormalities

Late childhood or adult (4 to 10 y)

transient if early treatment

25%

+

Decreased proprioception

Late childhood or adult (4 to 10 y)

transient if early treatment

0%

+

Cardiomyopathy/Biological signs

Adult

permanent?

0%

+

Normal TG§

Infancy (1 to 6 m)

transit or permanent

90%

+++

Low Total cholesterol§§

Infancy (1 to 6 m)

permanent

100%

moderate decrease ++

Low LDL

Infancy (1 to 6 m)

permanent

100%

moderate decrease ++

Low HDL††

Infancy (1 to 6 m)

permanent

100%

+++

Normal Fasting lipids in parents

  

100%

+

High CK (N < 100 mmol/L)

Infancy (1 to 6 m) - (460 ± 100)

permanent

60%

+++

Hepatic cytolysis (ALT < 40 mmol/L)

Infancy to late childhood - (60 ± 20)

transient or permanent

95%

+

Vitamin E deficiency (N > 18.4 μmol/L)

Infancy (1 to 6 m) - (2.7 ± 0.3)

permanent

95%

+

Vitamin A deficiency (N > 1.61 μmol/L)

Infancy (1 to 6 m) - (0.8 ± 0.5)

transit if supplementation

70%

+

Vitamin D deficiency (N > 50 nmol/L)

Infancy (1 to 6 m) - (31 ± 17)

transit if supplementation

45%

+

Vitamin K deficiency (N > 2.26 mmol/L)

Infancy (1 to 6 m) - (1.15 ± 0.6)

transit if supplementation

45%

+

Steatorrhea (N < 5 g/d)

Infancy (1 to 6 m) - (7.5 ± 3.6)

transit or permanent

85%

+

Negative Oral Fat Load

Infancy (1 to 6 m)

Permanent ?

100%

+

No acantocytosis

Infancy (1 to 6 m)

transit or permanent

90%

+++

EFA deficiency* (20:3n-9/20:4n-6)

Infancy to late childhood

permanent but variations

55%

+

Endoscopic and histological signs

    

White duodenal mucosa

Infancy (1 to 6 m)

permanent? Fat load dependent

100%

++

Enterocyte vacuolization, chylomicron-like

Infancy (1 to 6 m)

permanent? Fat load dependent

100%

++

  1. +: no; ++: few; +++: highly discriminative; N: normal
  2. § X value (mmol/L) is the same in CRD as in controls (0.73)
  3. §§ X value (mmol/L) is decreased by 60% in CRD (1.49 ± 0.56) vs controls (3.73 ± 0.80)
  4. X value (mmol/L) is decreased by 75% in CRD (0.69 ± 0.38) vs controls (2.33 ± 0.64)
  5. †† X value (mmol/L) is decreased by 5% in CRD (0.46 ± 0.08) vs controls (1.07 ± 0.22)
  6. *X ratio in CRD is 0.04 ± 0.02 and 0.01 ± 0.005 in controls